Trial intelligence / Profile preview

ED95 and efficacy comparison of tegileridine fumarate vs fentanyl for hysteroscopic surgery sedation

ChiCTR2500107995Phase 2Not yet recruiting

Sponsor
First Affiliated Hospital of Gannan Medical University
Start
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of tegileridine in perioperative pain and procedural pain (4 arms), sponsored by First Affiliated Hospital of Gannan Medical University. Primary endpoint: ED95 of tegileridine fumarate + propofol for hysteroscopic surgery. Planned start Aug 2025; status: not yet recruiting.

02

Drugs

tegileridine
03

Conditions

perioperative painprocedural pain

Beyond the preview

Go deeper on ChiCTR2500107995.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500107995.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call